036220 — Osang Healthcare Co Income Statement
0.000.00%
- KR₩105bn
- KR₩115bn
- KR₩129bn
Annual income statement for Osang Healthcare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 132,327 | 193,893 | 355,847 | 80,488 | 128,629 |
| Cost of Revenue | |||||
| Gross Profit | 47,617 | 98,033 | 221,108 | 25,570 | 57,145 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 139,411 | 144,629 | 213,029 | 105,292 | 118,272 |
| Operating Profit | -7,084 | 49,264 | 142,818 | -24,803 | 10,357 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 38.1 | 51,840 | 152,435 | -23,055 | 2,530 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,473 | 40,661 | 116,665 | -11,391 | 3,107 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,460 | 40,647 | 116,436 | -11,364 | 3,109 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,460 | 40,647 | 116,436 | -11,364 | 3,109 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 107 | 2,977 | 8,652 | -837 | -152 |
| Dividends per Share |